Rapport Therapeutics (RAPP) Interest & Investment Income (2023 - 2026)
Rapport Therapeutics (RAPP) reported Interest & Investment Income of $4.4 million for Q1 2026, up 43.12% year-over-year from $3.0 million in Q1 2025, and down 8.18% quarter-over-quarter from $4.7 million in Q4 2025.
Rapport Therapeutics (RAPP) Interest & Investment Income (2023 - 2026) Analysis & Trends
Rapport Therapeutics (RAPP) has 4 years of Interest & Investment Income data on file, last reported at $4.4 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $4.4 million, up 43.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.9 million (up 11.68% YoY), and the FY2025 annual result was $13.6 million, up 12.18% from the prior year.
- Interest & Investment Income eased to $4.4 million in Q1 2026 per RAPP's latest filing, from $4.7 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $4.7 million in Q4 2025 and troughed at $221000.0 in Q2 2023.
- A 4-year average of $2.7 million and a median of $2.9 million in 2025 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2024 and 2025: Interest & Investment Income soared 1112.22% in 2024, then declined 25.4% in 2025.
- A 4-year view of Interest & Investment Income shows it stood at $1.4 million in 2023, then jumped by 157.53% to $3.5 million in 2024, then jumped by 34.03% to $4.7 million in 2025, then declined by 8.18% to $4.4 million in 2026.
- Business Quant data shows RAPP's Interest & Investment Income at $4.4 million in Q1 2026, $4.7 million in Q4 2025, and $3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | Rapport Therapeutics | 1.66 Bn | 1.66 Bn | - | 4.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.36 Mn |
| Dec 31, 2025 | 4.75 Mn |
| Sep 30, 2025 | 3.06 Mn |
| Jun 30, 2025 | 2.76 Mn |
| Mar 31, 2025 | 3.05 Mn |
| Dec 31, 2024 | 3.54 Mn |
| Sep 30, 2024 | 4.10 Mn |
| Jun 30, 2024 | 2.68 Mn |
| Mar 31, 2024 | 1.82 Mn |
| Dec 31, 2023 | 1.38 Mn |
| Sep 30, 2023 | 856,000.00 |
| Jun 30, 2023 | 221,000.00 |